You start a GLP-1 medication.
A friend starts one around the same time.
Three months later, they've lost more weight than you have.
Or maybe you're experiencing strong appetite suppression while someone else says they barely notice a difference. One person has nausea during their first few weeks. Another has almost no side effects.
It's easy to wonder:
Is my GLP-1 working?
The answer isn't always found by comparing your experience with someone else's.
Individual responses to weight-management medications vary, and GLP-1 treatment is no exception. The National Institute of Diabetes and Digestive and Kidney Diseases notes that results from prescription weight-management medications vary both by medication and by person.
Your GLP-1 journey is influenced by much more than the name printed on your prescription.
One of the biggest misconceptions surrounding GLP-1 treatment is that everyone should follow roughly the same trajectory.
Week 1: appetite disappears.
Month 1: lose a certain number of pounds.
Month 3: reach a particular percentage of weight loss.
Real life isn't that predictable.
Clinical trials tell us what happened across large groups of participants. They are extremely useful for understanding the average effects of a medication, but an average isn't a promise about what will happen to one particular person.
Some people respond strongly.
Some respond gradually.
Others may not achieve the response they or their healthcare provider hoped for.
NIDDK specifically notes that weight-loss results from medications vary by the medication and the individual.
That's why your progress should be evaluated in the context of your own starting point, health, treatment plan, and response.
Losing 20 pounds means something very different for someone who starts at 180 pounds than it does for someone who starts at 300 pounds.
That's one reason clinical research often reports weight loss as a percentage of starting body weight rather than simply the number of pounds lost.
Consider two hypothetical patients:
Patient A starts at 200 pounds and loses 20 pounds.
Patient B starts at 300 pounds and loses 25 pounds.
Patient B lost more pounds, but Patient A lost a greater percentage of their starting weight.
Neither number, by itself, tells us whose treatment is going “better.”
Starting weight is only one of many differences between patients.
Weight regulation is complicated.
It's influenced by systems controlling appetite, energy expenditure, fat storage, hormones, and metabolism.
Genetics can influence how much fat someone stores, where they carry it, appetite regulation, and even aspects of physical activity.
This helps explain why two people can follow seemingly similar routines and still experience different outcomes.
It also challenges the idea that weight management is simply a matter of willpower.
Your body isn't identical to anyone else's.
Your treatment response doesn't have to be either.
“I'm on a GLP-1” doesn't tell the whole story.
There are multiple medications within or related to this category, and they aren't identical.
Semaglutide is a GLP-1 receptor agonist, for example, while tirzepatide acts on both GIP and GLP-1 receptors. These medications have different approved uses, dosing schedules, clinical evidence, and treatment considerations.
Even two people taking the same medication may be at completely different stages of dose escalation.
Someone who has been receiving treatment for nine months shouldn't necessarily compare their experience with someone who started six weeks ago.
Many GLP-1-based treatment plans begin at a lower dose and gradually increase according to the medication's dosing instructions and the patient's clinical situation.
That means the first few weeks or months of treatment may look very different from later stages.
Some patients notice appetite changes early.
Others notice more significant effects after progressing through treatment.
Dose changes should be guided by the prescribing clinician rather than accelerated simply because someone else's results appear faster.
Faster isn't automatically better.
The appropriate dose is the one determined with your healthcare provider based on the medication, your response, tolerability, and clinical needs.
Two people can have the same weight and still have very different metabolic health.
One person may be living with type 2 diabetes.
Another may have PCOS.
Someone else may take medications that affect body weight.
Others may have health conditions that influence weight regulation or their treatment plan.
NIDDK identifies several health conditions and medications that may contribute to weight gain or affect weight management, including some endocrine conditions and certain medicines used for other chronic conditions.
That's another reason GLP-1 treatment shouldn't be reduced to a competition over pounds lost.
Nutrition and exercise get most of the attention in weight-management conversations.
Sleep deserves a place there too.
Insufficient sleep has been associated with weight gain and may influence hunger, food choices, and calorie intake. NIDDK recommends that most adults ages 18 to 64 generally get seven to nine hours of sleep per night.
Someone consistently sleeping eight hours and someone sleeping five hours aren't necessarily starting from the same physiological environment.
That doesn't mean poor sleep explains every plateau.
It means metabolic health is influenced by more variables than medication alone.
GLP-1 medications can reduce appetite and help people feel full sooner, but they don't make nutrition irrelevant. Weight-management medications are generally intended to complement healthy eating and physical activity rather than replace them.
Food quality, portion sizes, protein intake, hydration, fiber, and overall calorie intake can all differ substantially between people.
And eating less isn't necessarily the only goal.
During significant weight loss, maintaining adequate nutrition becomes especially important.
Your care plan should help you build habits that support your health during treatment, not simply encourage you to eat as little as possible.
Two people losing the same amount of weight aren't necessarily experiencing the same change in body composition.
Physical activity, particularly resistance training, can be an important part of a comprehensive weight-management strategy.
That's another reason the scale doesn't tell the entire story.
Depending on the individual, progress may also be reflected in changes in:
• Waist circumference
• Physical fitness
• Strength
• Blood glucose
• Blood pressure
• Triglycerides
• Mobility
• Energy levels
• Other metabolic markers
Even modest weight loss can produce meaningful improvements in some health risk factors.
Results aren't the only thing that varies between patients.
Side effects do too.
One person may experience nausea after increasing their dose.
Another may struggle with constipation.
Someone else may experience relatively few gastrointestinal symptoms.
The presence or absence of side effects doesn't necessarily tell you how successful treatment will ultimately be.
And experiencing stronger side effects does not mean the medication is “working better.”
Side effects should be discussed with your healthcare provider, particularly if they're severe, persistent, or interfering with your ability to eat, drink, or function normally.
This may be one of the biggest challenges for today's GLP-1 patients.
Your feed isn't a clinical trial.
People are much more likely to post:
“I lost 50 pounds!”
than:
“I've been steadily progressing for six months and my results are pretty average.”
Extreme transformations naturally attract attention.
They can also create unrealistic expectations.
You may not know someone's starting weight, medication, dose, medical conditions, diet, activity level, treatment duration, or whether the story they're sharing is even representative of their entire experience.
Comparing your complete medical journey with someone else's highlight reel rarely gives you useful information.
The scale can be useful.
It just shouldn't necessarily be the only measure of progress.
Depending on your health and treatment goals, your care team may consider several indicators.
These might include:
Weight trends
Look at changes over weeks and months rather than becoming overly focused on daily fluctuations.
Percentage of starting weight lost
This can provide more context than pounds alone.
Waist circumference or body composition
These may provide additional information about physical changes.
Metabolic markers
Blood glucose, A1C, blood pressure, lipids, and other laboratory values may matter depending on your health conditions.
How you feel
Appetite, mobility, energy, sleep, and your ability to participate in everyday activities can also be relevant.
A 5% to 10% reduction in starting body weight may improve measures such as blood sugar, blood pressure, and triglycerides in some people.
Progress can therefore be meaningful before someone reaches their ultimate goal weight.
Don't immediately assume you need a higher dose.
And don't change your dose because someone online is taking more.
Instead, talk with your healthcare provider.
They can look at the bigger picture:
How long have you been taking the medication?
What dose are you currently taking?
Has your appetite changed?
How has your weight trended over time?
Are you experiencing side effects?
Are other medications affecting your weight?
How are your nutrition, activity, and sleep?
Are there medical conditions that need to be considered?
Is the current treatment still appropriate?
Choosing and evaluating weight-management medication should take into account factors such as potential benefits, side effects, existing health conditions, other medications, family medical history, and cost.
Sometimes the right answer is patience.
Sometimes the treatment plan needs adjustment.
And sometimes a different approach may be more appropriate.
That's what individualized care is designed to determine.
GLP-1 treatment isn't a race.
The person who loses weight faster isn't automatically healthier.
The person taking the highest dose isn't automatically receiving better treatment.
And the person posting the most dramatic transformation online isn't the standard your body needs to follow.
Obesity itself is influenced by a complex combination of lifestyle, sleep, medications, health conditions, environment, family history, and genetics.
It makes sense that treatment responses would differ too.
At Pomegranate, we believe the more useful question isn't:
“Why am I not losing as quickly as someone else?”
It's:
“Is my treatment moving my health in the right direction?”
That is a conversation worth having with your care team.
Medical Disclaimer
This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Individual responses to GLP-1 and other weight-management medications vary. Medication selection, dosing, dose changes, and treatment decisions should be made with a qualified healthcare professional.
Get quick answers to the most common questions about our platform and services.
